Recently approved in the US, the weight-loss drug Zepbound will reach more people in 2024, with research suggesting its effects trump those of the much talked-about Wegovy and Ozempic
Recently approved in the US, the weight-loss drug Zepbound will reach more people in 2024, with research suggesting its effects trump those of the much talked-about Wegovy and Ozempic Recently approved in the US, the weight-loss drug Zepbound will reach more people in 2024, with research suggesting its effects trump those of the much talked-about Wegovy and Ozempic